A review of the treatment of 222 patients with malignant tumours of the thyroid gland.
D000230:Adenocarcinoma / Q000601:surgery / Q000628:therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000628:therapy; D002277:Carcinoma / Q000601:surgery / Q000628:therapy*; D002291:Carcinoma, Papillary / Q000601:surgery / Q000628:therapy*; D002648:Child; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D013964:Thyroid Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D014284:Triiodothyronine; D013974:Thyroxine